REFERENCES
  1. Iwasaki YK, Nishida K, Kato T, Nattel S. Atrial fibrillation pathophysiology: implications for management. Circulation . 2011;124(20):2264-2274. doi:10.1161/CIRCULATIONAHA.111.019893
  2. Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol . 2015;12(4):230-243. doi:10.1038/nrcardio.2015.2
  3. Kusayama T, Furusho H, Kashiwagi H, et al. Inflammation of left atrial epicardial adipose tissue is associated with paroxysmal atrial fibrillation. J Cardiol . 2016;68(5):406-411. doi:10.1016/j.jjcc.2015.11.005
  4. Larsen BT, Maleszewski JJ, Edwards WD, et al. Atrial giant cell myocarditis: a distinctive clinicopathologic entity. Circulation . 2013;127(1):39-47. doi:10.1161/CIRCULATIONAHA.112.128900
  5. Mccrea PC, Childers RW Two unusual cases of giant cell myocarditis associated with mitral stenosis and with Wegener’s syndrome. Br Heart J . 1964;26(4):490-498. doi:10.1136/hrt.26.4.490
  6. Wohlgelernter D, Otis CN, Batsford WP, Cabin HS. Myocarditis presenting with ”silent” atrium and left atrial thrombus. Am Heart J . 1984;108(6):1557-1558. doi:10.1016/0002-8703(84)90711-7
  7. Gillie I, Fox H. Mitral stenosis together with a giant cell myocarditis limited to the left atrium. J Clin Pathol . 1968;21(6):750-752. doi:10.1136/jcp.21.6.750
  8. Thachil A, Christopher J, Sastry BK, et al. Monomorphic ventricular tachycardia and mediastinal adenopathy due to granulomatous infiltration in patients with preserved ventricular function. J Am Coll Cardiol . 2011;58(1):48-55. doi:10.1016/j.jacc.2011.02.044
  9. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration with the Society of Thoracic Surgeons [published correction appears in Circulation. 2019 Aug 6;140(6):e285]. Circulation . 2019;140(2):e125-e151. doi:10.1161/CIR.0000000000000665
  10. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr . 2015;28(1):1-39.e14. doi:10.1016/j.echo.2014.10.003
  11. Reményi B, Wilson N, Steer A, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease–an evidence-based guideline. Nat Rev Cardiol . 2012;9(5):297-309. Published 2012 Feb 28. doi:10.1038/nrcardio.2012.7
  12. Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1305-23.
  13. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation . 1997;96(4):1180-1184. doi:10.1161/01.cir.96.4.1180
  14. Maixent JM, Paganelli F, Scaglione J, Lévy S. Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol . 1998;9(6):612-617. doi:10.1111/j.1540-8167.1998.tb00942.x
  15. Basso C, Corrado D, Rossi L, Thiene G. Ventricular preexcitation in children and young adults: atrial myocarditis as a possible trigger of sudden death. Circulation . 2001;103(2):269-275. doi:10.1161/01.cir.103.2.269
  16. Ohira H, Tsujino I, Ishimaru S, et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging . 2008;35(5):933-941. doi:10.1007/s00259-007-0650-8
  17. Watanabe E, Miyagawa M, Uetani T, et al. Positron emission tomography/computed tomography detection of increased 18F-fluorodeoxyglucose uptake in the cardiac atria of patients with atrial fibrillation. Int J Cardiol . 2019;283:171-177. doi:10.1016/j.ijcard.2018.10.106
  18. Frustaci A, Cameli S, Zeppilli P. Biopsy evidence of atrial myocarditis in an athlete developing transient sinoatrial disease. Chest . 1995;108(5):1460-1462. doi:10.1378/chest.108.5.1460
  19. Yalagudri S, Zin Thu N, Devidutta S, et al. Tailored approach for management of ventricular tachycardia in cardiac sarcoidosis. J Cardiovasc Electrophysiol . 2017;28(8):893-902. doi:10.1111/jce.13228